Related Experiment Video
Updated: Aug 9, 2026
07:52
Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma
Kyung Sun Lee1, Kyung Hoon Min, So Ri Kim
1Department of Internal Medicine, Chonbuk National University Medical School, San 2-20 Geumam-dong, Deokjin-gu, Jeonju, Jeonbuk 561-180, Republic of Korea.
American Journal of Respiratory and Critical Care Medicine
|April 29, 2006
Summary
Vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) are elevated in asthma patients. VEGF signaling regulates MMP-9, suggesting a therapeutic target for asthma.
Area of Science:
- Pulmonary Medicine
- Immunology
- Molecular Biology
Background:
- Vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) are key mediators in asthma pathogenesis.
- Their roles in airway inflammation and remodeling are critical.
Purpose of the Study:
- To investigate the relationship between VEGF and MMP-9 in asthma.
- To elucidate the mechanisms of VEGF signaling in regulating MMP-9 expression.
Main Methods:
- Correlation analysis of VEGF and MMP-9 levels in asthma patient sputum.
- Assessment of VEGF receptor inhibitors in a murine asthma model.
Main Results:
- Asthma patients exhibit significantly higher VEGF and MMP-9 levels compared to healthy controls.
- A positive correlation was observed between VEGF and MMP-9 levels.
- VEGF receptor inhibition reduced asthma symptoms and MMP-9 expression in a murine model.
Conclusions:
- VEGF and MMP-9 expression are closely linked in asthma.
- VEGF signaling critically regulates MMP-9 expression, impacting asthma initiation and maintenance.
- Targeting VEGF receptors may offer a therapeutic strategy for asthma.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:23Role of Matrix Metalloproteases in Degradation of ECM
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
A...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:42The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.Composition of the Extracellular MatrixThe extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse molecules.